HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
39.2 USD
-0.82 (-2.05%)
39.26 USD
+0.06 (+0.15%)
Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 101 industry peers in the Health Care Providers & Services industry. HIMS has only an average score on both its financial health and profitability. HIMS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of HIMS (5.99%) is better than 83.17% of its industry peers.
The Return On Equity of HIMS (23.03%) is better than 91.09% of its industry peers.
HIMS has a better Return On Invested Capital (5.84%) than 61.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a better Profit Margin (6.05%) than 81.19% of its industry peers.
HIMS has a Operating Margin of 5.96%. This is in the better half of the industry: HIMS outperforms 64.36% of its industry peers.
With an excellent Gross Margin value of 75.01%, HIMS belongs to the best of the industry, outperforming 89.11% of the companies in the same industry.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.62 indicates that HIMS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.62, HIMS belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
HIMS has a Debt to FCF ratio (8.13) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
HIMS has a worse Debt to Equity ratio (1.67) than 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.62 |
ROIC/WACC0.67
WACC8.75%
2.3 Liquidity
A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.88, HIMS is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
A Quick Ratio of 1.64 indicates that HIMS should not have too much problems paying its short term obligations.
The Quick ratio of HIMS (1.64) is better than 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.02%.
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 21.08% on average per year.
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y21.08%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 72.59 indicates a quite expensive valuation of HIMS.
HIMS's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of HIMS to the average of the S&P500 Index (26.46), we can say HIMS is valued expensively.
A Price/Forward Earnings ratio of 48.38 indicates a quite expensive valuation of HIMS.
The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
The average S&P500 Price/Forward Earnings ratio is at 36.10. HIMS is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.59 | ||
| Fwd PE | 48.38 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.69 | ||
| EV/EBITDA | 52.6 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
HIMS's earnings are expected to grow with 23.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.11
PEG (5Y)1.2
EPS Next 2Y22.49%
EPS Next 3Y23.43%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
39.2
-0.82 (-2.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.61%
Inst Owner Change15.84%
Ins Owners10.28%
Ins Owner Change-1.82%
Market Cap8.92B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target49.13 (25.33%)
Short Float %32.97%
Short Ratio2.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-1.34%
PT rev (3m)-4.37%
EPS NQ rev (1m)-45.88%
EPS NQ rev (3m)-47.66%
EPS NY rev (1m)0.13%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)-1.99%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.59 | ||
| Fwd PE | 48.38 | ||
| P/S | 4.04 | ||
| P/FCF | 74.69 | ||
| P/OCF | 27.45 | ||
| P/B | 15.36 | ||
| P/tB | 70.37 | ||
| EV/EBITDA | 52.6 |
EPS(TTM)0.54
EY1.38%
EPS(NY)0.81
Fwd EY2.07%
FCF(TTM)0.52
FCFY1.34%
OCF(TTM)1.43
OCFY3.64%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)6.11
PEG (5Y)1.2
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.62 |
F-Score3
WACC8.75%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.46%
EBIT Next 3Y94.49%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 11.88% in the next year.